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Developmental ocular malformations, including anophthalmia-microphthalmia (AM), are heterogeneous disorders with frequent
sporadic or non-Mendelian inheritance. Recurrent interstitial deletions of 14q22-q23 have been associated with AM, sometimes with
poly/syndactyly and hypopituitarism. We identify two further cases of AM (one with associated pituitary anomalies) with a 14q22-q23
deletion. Using a positional candidate gene approach, we analyzed the BMP4 (BoneMorphogenetic Protein-4) gene and identiﬁed a frame-
shift mutation (c.226del2, p.S76fs104X) that segregated with AM, retinal dystrophy, myopia, brain anomalies, and polydactyly in a fam-
ily and a nonconservative missense mutation (c.278A/G, p.E93G) in a highly conserved base in another family. MR imaging and trac-
tography in the c.226del2 proband revealed a primary brain developmental disorder affecting thalamostriatal and callosal pathways, also
present in the affected grandmother. Using in situ hybridization in human embryos, we demonstrate expression of BMP4 in optic ves-
icle, developing retina and lens, pituitary region, and digits strongly supporting BMP4 as a causative gene for AM, pituitary, and poly/
syndactyly. Because BMP4 interacts with HH signaling genes in animals, we evaluated gene expression in human embryos and demon-
strate cotemporal and cospatial expression of BMP4 and HH signaling genes. We also identiﬁed four cases, some of whom had retinal
dystrophy, with ‘‘low-penetrant’’ mutations in both BMP4 andHH signaling genes: SHH (Sonic Hedgehog) or PTCH1 (Patched). We propose
that BMP4 is a major gene for AM and/or retinal dystrophy and brain anomalies and may be a candidate gene for myopia and poly/
syndactyly. Our ﬁnding of low-penetrant variants in BMP4 and HH signaling partners is suggestive of an interaction between the two
pathways in humans.Introduction
Developmental ocular malformations, including anoph-
thalmia (MIM 206900), microphthalmia (MIM 206900),
and coloboma (MIM 120200), affect ~1 in 3–4000 individ-
uals and are responsible for over a quarter of childhood
blindness worldwide.1,2 Over half of anophthalmia mi-
crophthalmia (AM) cases are associated with systemic
anomalies, although over 75% of these are not yet part of
well-deﬁned syndromes.2 Although recessive, dominant,
and X-linked modes of inheritance of AM have all been de-
scribed, sporadic or non-Mendelian inheritance patterns
are highly prevalent, and this initially hampered the identi-
ﬁcation of genes responsible for AM. Recently, progress has
beenmade through variousmethods including a positional
candidate gene approach in which recurrent interstitial de-
letions in chromosome 14q22-q23 associated with AM led
to the identiﬁcation of OTX2 (MIM 600037) as a gene for
microphthalmia and retinal dystrophy (MIM 120970).3304 The American Journal of Human Genetics 82, 304–319, FebruaryAlthough OTX2 has been identiﬁed as a causative gene
for AM within this region,3 this may not account for all
cases and does not explain a complex phenotype that in-
cludes hypopituitarism (MIM 313430) and digit anoma-
lies4,5 because OTX2 is not expressed in the pituitary gland
or digits during development.
BMP4 (MIM 112262), which is located in 14q22-q23, is
an excellent candidate gene for both ocular malformation
and digit anomalies including poly/syndactyly. It is amem-
ber of the BMP family and transforming growth factor-b1
(TGF-b1 [MIM 190180]) superfamily of secretory signaling
molecules that play essential roles in embryonic develop-
ment.6,7 The BMP4 gene is composed of four exons (al-
though only exons 3 and 4 are translated); the protein is
408 amino acids long and consists of a TGF-b1 propeptide
domain and a TGF-b domain that forms an active dimer.8
Bmp dimers initiate signaling by binding to both type I
and type II serine or threonine kinase receptors. Upon li-
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receptor, which then triggers an intracellular signaling
cascade involving proteins of the SMAD family.
Bmp4 and Bmp7 (MIM 112267), another member of the
Bmp family, are critical in dorsoventral patterning of the
optic vesicle in mice.9,10 Both Bmp4 and Bmp7 cooperate
with Pax6 (MIM 607108), a fundamental eye-development
gene, in lens placode formation.11 Furthermore, Bmp4 can
replace the activity of Sox2 (MIM 184429), another gene
with a critical role in early ocular development,12–14
thereby allowing the progression of eye development in
Sox2 null mice.9 In mice, although Bmp4/ homozygotes
die in early embryogenesis, Bmp4þ/ heterozygotes exhibit
AM (35%), failure of lens induction, anterior segment dys-
genesis (MIM 107250), and retinal and optic nerve aplasia
(MIM 179900 and 165550, respectively).9,15, 16 Extraocular
features include cystic kidney, polydactyly (MIM 603596),
and craniofacial malformations.15 Furthermore, excessive
Bmp4 signaling can also lead to reduced ocular growth
with small and misshapen eyes.17
We screened 215 individuals with ocular malforma-
tions, mainly AM, for cytogenetic defects by chromosome
analysis, gene deletions by MLPA (multiplex-ligation-
dependent probe ampliﬁcation), and mutations in the
BMP4 gene by direct sequencing. Here, we report on the
identiﬁcation of two individuals with a 14q22-q23 dele-
tion, a frameshifting mutation in the coding region of
the BMP4 gene in a familial case of anophthalmia, retinal
dystrophy, brain malformation, and poly/syndactyly and
a BMP4-coding-region missense mutation in another fam-
ily. We performed structural magnetic resonance imaging
(MRI) and connectivity studies of the brain of two individ-
uals with the BMP4 frameshift mutation. We studied the
expression patterns of BMP4, SHH (MIM 600725), PTCH1
(MIM 601309), GLI1 (MIM 165220), and GLI3 (MIM
165240) (downstream targets of SHH) in early humanThe Ameembryos and demonstrate cotemporal and cospatial ex-
pression of BMP4 and HH signaling partners, thereby
highlighting their possible genetic interactions during
eye, brain, and digit development. In addition, we de-
scribe four individuals with genetic variation in both
BMP4 and SHH/PTCH1 genes.Material and Methods
Patients and Controls
A total of 215 individuals with ocular malformation defects, prin-
cipally anophthalmia, microphthalmia, and coloboma, were
recruited as part of a national anophthalmia study based at Moor-
ﬁelds Eye Hospital, London and Birmingham Children’s Hospital,
Birmingham, UK. Where possible, ultrasound of the globes and
visual electrophysiology were performed. Informed consent was
obtained, and each patient was examined by an ophthalmic ge-
neticist (NR) and pediatrician (AS). Ethics approval was obtained
for the study from Huntingdon Ethics Committee 04/Q0104/
129. DNA from 192 healthy adults (European collection of cell cul-
tures [ECACC]) was screened as controls. Family members of pos-
itive variants were analyzed if DNA was available.Visual Electrophysiology
International-standard full-ﬁeld electroretinograms (ERGs) were
recorded for assessment of generalized retinal function.18 The
standard full-ﬁeld ERG protocol involved the use of gold-foil cor-
neal recording electrodes and incorporated the rod-speciﬁc and
standard ﬂash ERG, both recorded under conditions of dark adap-
tation, and the photopic 30 Hz ﬂicker and single-ﬂash ERGs, both
recorded after a standard period of light adaptation. A stimulus 0.6
log units greater than the ISCEV-standard ﬂash was also used, so
that the bright ﬂash ERG a-wave under conditions of dark adapta-
tion could be better demonstrated. In some young individuals,
and those unable to tolerate corneal electrodes and Ganzfeld
stimulation, recordings were performed with periorbital skinTable 1. Primer Pairs Used to Amplify the BMP4 Gene
Primer Sequence (50–30)
Exon Annealing Temp (C) Forward Reverse
1 63.5 CTAGGCGAGGTCGGGCGGCTGGAG CACCTTTTGCCTCGGTCACAGC
2 55 GCTCACGTGACTCCGAGGGGC CAGGGAGCAGAGTGTGGATATTGTAAAGG
3 50.5 TGCCCCTCCATTTCTAGC ACTGGGGCTTTGATGTAACC
4a 60 TAGGTTTCCCCTGCATAAGC GCTTAGGGCTACGCTTGG
4b 55 ATTAGCCGATCGTTACC GTCCAGCTATAAGGAAGCTable 2. Primer Pairs Used to Amplify the SHH Gene
Primer Sequence (50–30)
Exon Annealing Temp (C) Forward Reverse
1a 60 TGCCATTCCAGCCCCTGTCTGGGT CCTAGGGTCTTCTCGGCCACATTGG
1b 60 CTCCTCGCTGCTGGTATGCTCGGGAC TTCCTATCTGCCCGAAGAGCAAACAGAG
2a 60 GGCAGGCTGATGGAGGGGCCGGGA GACGTGGTGATGTCCACTGCGCGGC
2b 60 CCACTCAGAGGAGTCTCTGCACTA AAACGCAGTCATCGCCCAGCGACCCTGC
3a 50 TAGGAGCGCGGGCACCAAGCGT AGTCGTTGTGCGGCGCCACAAAG
3b 54 TCACTTTCCTGGACCGCGACGAC AGTGCAGCCAGGAGCGCGTGCG
3c 56 GGTCATCGAGGAGCACAG GGTCCTTGTTTCCTTAGAGTCTArican Journal of Human Genetics 82, 304–319, February 2008 305
Figure 1. MLPA Analysis of Cases 1 and 2, BMP4 Mutational Analysis of Cases 3 and 4, and Clinical and Pedigree Data of Case 3
(A) MLPA of case 1 and 2. The figure shows a region of the Genotyper trace that includes the BMP4 and OTX2 peaks plus four control peaks.
A deletion of the BMP4 and OTX2 MLPA probe binding site is demonstrated by a 50% reduction in peak height.
(B) BMP4 mutation analysis in two families with congenital eye abnormalities. The top row shows a schematic diagram of the human BMP4
cDNA with the positions of the exons and their corresponding translated protein domains. Filled black circles indicate locations of
mutations; color-coded vertical arrowheads show the position of each mutation with the corresponding case number. The bottom row
shows sequence traces of the affected individuals and their family members (gmo, grandmother; mau, maternal aunt; and bro, brother).306 The American Journal of Human Genetics 82, 304–319, February 2008
electrodes, non-Ganzfeld (ﬂash) stimulation, and a shortened pe-
diatric ERG protocol,19 with the dark-adapted bright-ﬂash ERG
as an index of rod-system function and the light-adapted 30 Hz
ﬂicker ERG for assessment of the cone-system function. Pattern
ERGs (PERGs) evoked by high-contrast checkerboard reversal were
also recorded according to international standards.20 The PERG
P50 component was used as an index of macular function. Pattern
and ﬂash visual evoked potentials (VEPs) were recorded in some
cases to assess the integrity and function of the intracranial visual
pathways.19DNA Preparation, PCR, and MLPA
Genomic DNA was extracted from whole blood with a Nucleon
DNA extraction Kit (Tepnel Life Sciences). Ampliﬁcation of geno-
mic DNA was performed with 100 ng DNA. Primers are outlined
in Tables 1 and 2. The ﬁrst A of the ATG initiating methionine
of all genes described here is numbered nucleotide 1.
For BMP4 (Ensembl transcript ID ENST00000245451), PCR was
carried out with the following: 100 mM dNTP’s, 0.1 mM each
primer, 5 ml of 103 PCR ampliﬁcation buffer, and 1 U HotStar
Taq DNA polymerase (QIAGEN). For exons 4A and 4B, an extra
3 mM and 1 mM MgCl2 were added, respectively. Thermocycling
was performed as follows: step 1, 94C for 15 min; step 2.1,
94C for 30 s to 1 min; step 2.2, annealing temperatures as indi-
cated in Table 1 for 30 s to 1 min; step 2.3, 72C for 30 s to
1 min (35 cycles); and step 3, 72C for 10 min.
For SHH (Ensembl transcript ID ENST00000297261), PCRwas car-
ried out with the following: 200 mM dNTP’s (100 mM for exon 3B),
0.1 mM each primer (0.05 mM for exons 2A and 3B and 0.2 mM
for exon 3C), 5 ml of 103 PCR ampliﬁcation buffer, and 1 U
HotStar Taq DNA polymerase (QIAGEN). DMSO was added to
10% ﬁnal concentration for exon 3B, and an extra 1 mM MgCl2
was added for exon 3A. Thermocycling (35–40 cycles) was per-
formed as described above except for exon 3C when the denatur-
ation steps were at 98C (Table 2).
Regarding PTCH1 (Ensembl transcript ID ENSG00000185920):
For case 7, all exons21 of the PTCH1 gene were screened by dHPLC
analysis. Because exon 12b showed a variant band pattern (data
not shown), it was sequenced.
PCR products were run on a 2% agarose gel for ensuring ade-
quate yield and so that nonspeciﬁc products could be ruled out.
Unincorporated primers and dNTPs were removed by incubation
of 5 ml of PCR product with 1 ml of ExoSapIT (USB) for 1 hr at
37C and then 15 min at 80C. DNA sequencing was performed
bidirectionally with Big Dye version 3.1 (Applied Biosystems) as
recommended by the manufacturer.
Dosage analysis was carried out with MLPA probes designed spe-
ciﬁcally for exon 4 of both the BMP4 and OTX2 genes (sequences
available on request). The probes were diluted to 1.33 fmol/ml, and
1.5 ml of thiswas used forMLPA in conjunctionwith a commercially
available MLPA probe mix (Holoprosencephaly–P187; MRC-Hol-
land) to provide controls. The standard protocol of MRC-Holland
was used, and the initial DNA denaturation volume was reduced
to 3.5 ml to allow for the extra 1.5 ml of BMP4/OTX2 probe mix.The AmeNeuroimaging and Diffusion Tractography
Structural images of brain and eyeswere obtained on a3TTrio scan-
ner (Siemens) including fat-suppressed T1-weighted imaging (2D-
FSE, 0.6875 3 0.6875 3 3 mm3, TE 8 ms, and TR 750 ms) and
proton-density-weighted imaging of the orbits (2D-TSE, 0.47 3
0.47 3 3.6 mm3, TE 13 ms, and 80 ms, TR 3110 ms) and high-
resolution T1-weighted imaging of the brain (MP-RAGE, 1 3 1 3
1 mm3, TE 4.53 ms, TR 2200 ms, FA 8, TI 900 ms). With noninva-
sive MRI, we assessed the macroscopic structure and connectivity
between the thalamus and visual cortex as key structures connect-
ing the visual systemby employing probabilisticDT in thebrains of
case 3 and his affected grandmother and comparing them to imag-
ing ﬁndings in nine healthy controls. All image processing was
performed with software from FMRIB’s Software Library (FSL).
Probability distributions of ﬁber orientation were estimated at
every voxel as described previously.22 Diffusion-weighted imaging
(DWI) data acquisition was performed as described.23
For the visual masks, a threshold of 50% was applied to cy-
toarchitectonic probability data for visual areas V1 and V2 from
FZ Ju¨lich’s SPM Anatomy toolbox.24 These data were then trans-
formed into MNI152 space with afﬁne registration. The two data
sets were summed and binarized. Finally, the resulting mask was
split up into a left- and right-hemispheric target mask. Standard
space masks for thalami were obtained from a previous study, in
which they had been deﬁned manually.23 Laterality indices were
calculated for assessment of symmetry of connectivity to visual
cortex from thalamus. In a separate step, interhemispheric, trans-
callosal connectivity was assessed by establishment of connectiv-
ity probabilities between every voxel in each individual’s manu-
ally deﬁned callosal masks and predeﬁned cortical targets in
standard space.25 Connectivity was assessed as the percentage of
connectivity to any of the predeﬁned target masks, expressed as
a fraction of the healthy control’s overall callosal connectivity to
that prespeciﬁed target.
In Situ Hybridization
The expression patterns of BMP4, SHH, PTCH1, GLI1, and GLI3
were investigated by nonradioactive RNA in situ hybridization in
human embryos from Carnegie stages (CS) 13–23, which corre-
spond approximately to mouse Theiler stages 16–23 (E10.25–
E14.5). Human embryos were obtained from the Medical Research
Council/WellcomeTrustHumanDevelopmental BiologyResource,
with full ethical approval. Preparation of embryo sections andnon-
radioactive RNA in situ hybridization was performed as described
elsewhere.26 The templates for probes were as described previously
as follows: BMP4,9 SHH,27 PTCH1,28 GLI1,29 and GLI3.30Results
Patient Cohort
Of the 215 cases analyzed, 28 had bilateral anophthalmia,
40 had bilateral microphthalmia5 cataract; nine had uni-
lateral anophthalmia with contralateral microphthalmia;(C) Facial views of case 3 and his family members. (Ci) shows case 3 with right anophthalmia (wearing prosthesis), left microanterior seg-
ment with coloboma. (Cii) shows case 3 details of left eye with iris coloboma. (Ciii) shows case 3 left fundus with chorioretinal colobomas,
hypoplastic tilted disc. Shown in (Civ), the facial view of case 3;s grandmother. Shown in (Cv), feet of case 30s grandmother showing position
of right postaxial polydactyly (arrow). In (Cvi) is the facial view of case 3
0s mother. (Cvii) shows the pedigree of case 3, as follows: or ¼
myopia; or ¼ anophthalmia, microphthalmia and retinal dystrophy; or ¼ polydactyly; and or ¼ brain anomalies. Shown in
(Cviii), the right hand of case 3’s grandmother with webbing.rican Journal of Human Genetics 82, 304–319, February 2008 307
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mal eye or very minor defect; 34 had unilateral AM with
contralateral normal-sized eye but defect, e.g., retinal dys-
trophy and coloboma; 16 had isolated colobomas (nine
bilateral and seven unilateral); and seven had other anoma-
lies including cryptophthalmos (2) (MIM 123570), Peter’s
anomaly (2) (MIM 106210 and 180500), cone dystrophy
(1), microcornea (1), and congenital aphakia (1) (MIM
610256).
MLPA Analysis
Out of a cohort of 215 cases with AM, we identiﬁed two
cases with de novo cytogenetically visible 14q22-q23 dele-
tions. Case 1 [46XX, del(14)(q22.3q23.2)] had bilateral
anophthalmia, hypothyroidism, delayed motor develop-
ment, partial callosal agenesis (MIM 217990), and cere-
bellar vermis hypoplasia and case 2 [46XY, del(14)
(q22.2q23.1)] had bilateral anophthalmia, microcephaly,
sensorineural deafness, cryptorchidism (MIM 219050),
partial callosal agenesis, cerebellar and pituitary abnor-
malities, and developmental delay. The deletions were
demonstrated by MLPA to include both BMP4 and OTX2
(Figure 1A and Table 3).
BMP4 Mutation Analysis
Eighteen of the 215 probands showed sequence variation
within the BMP4 gene. The clinical details of fourteen cases
are shown in Table 3.
Case 3 (Figures 1Ci–1Ciii and Table 3) had right anoph-
thalmia and left microanterior segment, with the follow-
ing measurements: horizontal corneal diameter of 6 mm,
anatomical anterior chamber depth of 2.1 mm (N ¼
2.5 mm), and overall axial length of 26.4 mm (normal
range 22.5–24.5 mm, and normal average midrange
23.5 mm). He had iris and chorioretinal coloboma. There
was no pigmentary retinopathy, but a retinal dystrophy
was detected on electrodiagnostic testing. Full-ﬁeld ERGs
(Figure 2L) show moderate-to-severe amplitude reduction
and peak-time delay, consistent with generalized retinal
dysfunction affecting both rods and cones. Pattern ERG
P50 reduction was consistent with severe macular involve-
ment (Figure 2K). He also had learning difﬁculties, partial
callosal agenesis, and postaxial polydactyly of the feet.
He had a c.226del2, p.S76fs104X mutation within the
N-terminal region of the TGF-b1 propeptide domain. This
is predicted to truncate the protein at amino acid 104, ex-
cluding the functionalC-terminal regionof theTGF-b1pro-
peptide (amino acids 41–276) and TGF-b1 domains (amino
acids 308–408). BMP4 haploinsufﬁciency is likely to occur
through nonsense-mediated RNA decay. The proband’s
mother (Figure 1Cvi), grandmother (Figure 1Civ), and
aunt, who all have high myopia but not AM, carry
the same mutation; his normal two half-brothers do
not. The grandmother’s refraction is approximately
9.00 D, similar to that reported by the maternal aunt
who had previously undergone refractive surgery; the
mother has myopia by report but was unavailable for2008
study. The myopia in the proband (4.00 D) is lower
than that expected for the large posterior segment, prob-
ably because of a small anterior segment. The grand-
mother’s ERG demonstrated some decline in retinal func-
tion, but this was not deﬁnitely abnormal given her
age and given that testing had to be performed under
suboptimal conditions (surface electrodes). The grand-
mother also exhibited polydactyly and ﬁnger webbing (Fig-
ures 1Cv and 1Cviii); her sister (unavailable for study) has
polydactyly.
Case 4 with bilateral microphthalmia, broad hands,
low-placed thumbs, dysplastic nails, cryptorchidism, brain
anomalies, seizures, and developmental delay had
a c.278A/G, p.E93G transition. This mutation was also
present in the father who does not have AM but demon-
strates some mild inferior pigmentation of both retinas;
this pigmentation could be a forme fruste coloboma. The
substituted glutamic acid is highly conserved among mul-
tiple mammals and other vertebrates (Xenopus tropicalis
and Tetraodon nigroviridis) and is within a stretch of ﬁve
conserved glutamic acid residues. This suggests that this
substitution is likely to be signiﬁcant and to cause disrup-
tion to the structure of the BMP4 protein.
Six individuals (cases 5, 6, 7, 8, 10, and 11) had
a c.370þ28G/A substitution of a highly conserved base
in intron 3, predicted to affect BMP4 splicing (also present
in 3/186 control samples; data available upon request).
Four individuals (cases 9, 12, 13, and 14) had
a c.1217þ88C/T change in the 30 UTR of exon 4 (also
present in 6/191 control samples; data available upon re-
quest). Other changes in BMP4 that are likely to be incon-
sequential include two cases with a c.371-24C/T change
in intron 3, two cases with a c.76T/C, p.L26L change
which was also present in 1/186 controls, two cases with
a c.345C/T, p.N115N change, and 152 cases with a c.1-
1025C/T change that was present in 60/89 controls.
Cerebral Imaging and Connectivity Studies
of Case 3 and Grandmother
Case 3 demonstrated cerebral anomalies including en-
larged trigones, widened cerebral sulci, and marked thin-
ning of the corpus callosum on structural MRI (Figures
2A–2F). Furthermore, with DT, he showed pronounced
asymmetry in connectivity between the thalamus and
the occipital cortex when they were compared to imaging
in the control population. Analysis of transcallosal connec-
tivity showed reduced connectivity to cortical targets espe-
cially in primary sensorimotor and frontal areas (Figures
2G, 2H, 2I, and 2J).25 The thalamocortical asymmetry
could not be the result of right anophthalmia or chiasmal
hypoplasia because the changes would affect both path-
ways symmetrically. Structural MRI on the grandmother
who carried the same BMP4mutation revealed very similar
ﬁndings to the proband, namely enlarged ventricles,
marked widening of the cerebral sulci with generalized
atrophy, and marked thinning of the corpus callosum.
DT demonstrated asymmetry of the visual pathways. TheseThe Ameﬁndings show a remarkable consistency of brain pheno-
type.
Human Embryo In Situ Hybridization Studies
In light of evidence of an interaction between Bmp4 and
Hh signaling partners in animal models,15,31 we investi-
gated patterns of BMP4, SHH, PTCH1, GLI1, and GLI3
expression in the human developing eye, brain, and
hand plate.
In the eye, human BMP4 expression is seen dorsally in
the optic vesicle (CS13) and developing optic cup (CS14)
in keeping with its role in lens induction in animals.9 Later
at CS20, BMP4 is seen in the dorsal and ventral rim of the
optic cup (Figure 3). PTCH1 expression is seen in the dorsal
and ventral rim of the optic cup, whereas SHH is expressed
strongly in the posterior optic cup and optic nerve. At
CS17, SHH is expressed in the retinal ganglion cells, sup-
porting a role for SHH in retinal organization.32 There is
a reciprocal expression pattern of SHH and its antagonist
receptor, PTCH1, in the neural retina. GLI1 and GLI3 are
expressed posteriorly in the optic cup with reduced expres-
sion at the dorsal and ventral rim in a pattern similar to
that of SHH. At later stages of development, expression of
BMP4, SHH, and PTCH1 are conﬁned to the developing
lens (Figures 3L–3N).
In developing brain, BMP4 is strongly expressed in the
diencephalic ﬂoor, consistent with a role in pituitary devel-
opment (Figures 4A, 4F, and 4K), under the ﬂoor plate (Fig-
ures 4N and 4Q) and in the medial ganglionic eminence
(MGE) (Figures 4A, 4F, and 4K). Strong expression of SHH
is seen in the ﬂoor plate and the MGE of the diencephalon
(Figures 4B, 4G, 4L, 4O, and 4R), and such a ﬁnding is con-
sistent with its role in patterning of the central nervous
system and oligodendrogenesis within the MGE.33 Expres-
sion of PTCH1 is seen in the neuroepithelium lateral to
the ﬂoor plate, adjacent to the MGE, and very strongly in
the roof plate (Figures 4C, 4H, 4M, 4P, and 4S). The MGE
will develop into the amygdaloid nuclei in the adult brain.
In the temporal lobes of the brain, these are small oval
structures that are closely connected to the hypothalamus,
the hippocampus, and the cingulate gyrus. They form
part of the olfactory and limbic systems and play a role
in the sense of smell, motivation, and emotional behavior.
Expression of GLI1 is seen more strongly in the ventral
diencephalon and within Rathke’s pouch (Figures 4D and
4I), which develops into the adenohypophysis of the
anterior pituitary. GLI3 expression is seen more strongly
in the ventral diencephalon and within the infundibular
recess (Figures 4E and 4J), which grows down to meet
Rathke’s pouch and will form the posterior lobe of the
pituitary.
In the hand, BMP4 is expressed in the interdigital mesen-
chyme and the joint primordium at CS20, the stage at
which the limb buds have formed and are starting to differ-
entiate into ﬁngers (Figures 5A, 5D, and 5G). The extreme
distal ends of the ﬁngers are separate, but there is signiﬁ-
cant webbing more proximally between the digits of therican Journal of Human Genetics 82, 304–319, February 2008 311
hand. At CS23, which is the end of the embryonic period,
the ﬁngers are almost totally separate, and expression of
BMP4 at this stage is restricted to the joint-forming region
(Figures 5J, 5M, and 5P). There is stronger expression in the
joint capsules and the dense connective tissue. PTCH1 and
SHH are expressed in mutually exclusive areas in the hand
plate (Figure 5). PTCH1 is expressed both proximally and
dorsally to the developing digit, whereas SHH expression312 The American Journal of Human Genetics 82, 304–319, Februaryis seen within the perichondrium surrounding the distal
tip of the digit.
Our data show that patterns of expression in eye,9 brain,34
and hand plate35 in the human are similar to the mouse.
SHH and PTCH1 Mutation Analysis
Because cotemporal and cospatial expression of BMP4 and
HH signaling genes were observed in the eye, brain, andFigure 2. MR Imaging, Diffusion Tractography and Electrodiagnostic Results of Case 3 and Controls
MRI structural images (A–F) from case 3 (A and E) sagittal, (B) coronal, (C, D, and F) transaxial views demonstrating thinning of the
corpus callosum in (A), and symmetric widening of the lateral ventricles, particularly the trigones in (B) and (C). The hippocampal
(arrows, [D]) and sellar structures (E) appear intact. Orbital imaging (F) demonstrates right anophthalmia with a primary orbital implant
behind the ocular remnant and slightly enlarged size of the left globe with hypoplasia of anterior structures including iris, lens, and ciliary
apparatus. The right optic nerve and chiasm were atrophic, whereas the left optic nerve appeared intact. Thalamo-occipital connectivity
scans (G and H) in a representative control subject (G) show symmetrically formed visual pathways (hot colors, for example, red or orange
denotes strong evidence of connectivity) and normal structural imaging. In case 3 (H), asymmetry and disruption of the pathways are
shown. Diffusion tractography of case 3 and controls (I and J), which assesses connectivity from a manually defined callosal mask to
predefined cortical targets, namely prefrontal (PFC), premotor (PMC), primary motor (M1) and somatosensory (S1), occipital (OCC), tem-
poral (TMP), and parietal cortex (PPC), shows reduced interhemispheric connectivity especially relating to M1 and S1 in case 3, whereas
connectivity for OCC, TMP, and PPC appears relatively spared. Thalamocortical connectivity score in healthy controls ¼ 1.750.48 (mean
5 SD); case 3 ¼ 4.34; Z ¼ 5.47, p < 0.01). Visual evoked potentials and pattern ERGs (K) and full-field ERGs (L) from the left eye (LE) of
case 3 are compared with representative normal examples. Full-field ERGs show moderate-to-severe amplitude reduction and peak-time
delay, consistent with generalized retinal dysfunction affecting both rods and cones. Pattern ERG P50 component reduction is in keeping
with severe macular involvement. Pattern and flash VEPs are relatively well preserved. LU indicates log units greater (þ) or less () than
the ISCEV standard flash.2008
hand plate, we next investigated whether individuals with
mutations in BMP4 had coexisting mutations in SHH and
PTCH1. We found three cases with mutations in BMP4
and SHH and one with mutations in BMP4 and PTCH1.
Cases 3 (c.226 del2), 8 (c.370þ28G/A), and 9
(c.1217þ88C/T) each had a different BMP4mutation (Ta-
ble 3), but all had a c.1-125G/A change in the 50 UTR of
SHH predicted to affect an exonic splicing enhancer.36
This SHH change was also present in 16/191 controls, com-
pared to 32/215 individuals from our cohort. Interestingly,
Figure 3. Expression Studies of BMP4, SHH, PTCH1, GLI1, and
GLI3 in the Developing Human Eye
Eye formation in the human embryo at CS 13 (A and B), 14 (C), 17
(D–H), 20 (I–K), and 21 (L–N). Coronal sections through the eye
were analyzed by in situ hybridization for the expression for
BMP4 (A–D), SHH (E, J, and M), PTCH1 (F, K, and N), GLI1 (G),
and GLI3 (H). The following abbreviations are used: El, eye lid;
Lf, lens fiber; Rs, retina space; Nl, neural layer of optic cup; Ol,
outer layer of optic cup; Nr, neural retina; Rpe, retinal pigment ep-
ithelium; Le, lens; Ce, corneal ectoderm; On, optic nerve; Os, optic
stalk; Cse, corneal epithelium; and Dl, developing lens. The scale bar
for (A)–(H) represents 1000 mm and that for (I)–(N) 1000 mm.
Arrows indicate areas of strong expression.The Amecase 30s ocular phenotype was much more severe than
those of other family members with the same BMP4muta-
tion. Although, some family members of cases 3 and 8 had
a mutation in BMP4 or SHH, only the affected probands
had mutations in both genes; digenic mutations were
not present in 191 controls tested. Case 90s parents were
unavailable for study. The clinical features of cases 3, 8,
and 9 are shown in Table 3.
Case 7 had bilateral microphthalmia and developed two
periorbital basal cell carcinomas in her teens. This pheno-
type is suggestive of Gorlin syndrome (MIM 109400),
which is caused by a mutation in the PTCH1 gene, and we
identiﬁed a de novo mutation in PTCH1 (c.1835þ1G/A;
data available upon request) predicted to destroy the intron
12b splice donor site. In addition to this, she had
a c.370þ28G/A BMP4 mutation. Her mother also had
the BMP4 mutation, but only case 7 had mutations in
BMP4 and PTCH1. Her eye phenotype is muchmore severe
than that usually described for Gorlin syndrome.Discussion
Interstitial deletions of chromosome 14q22-q23 are rare,
and to date, only seven cases have been described, all
with AM.4,5,37–40 We describe two additional cases of AM
with extraocular anomalies associated with a de novo
14q22-q23 deletion. We undertook mutation analysis of
the BMP4 gene in this region in our cohort of individuals
with developmental eye anomalies and identiﬁed a previ-
ously unreported frameshift mutation in a family with
AM, retinal dystrophy, myopia, poly/syndactyly, and brain
anomalies that segregated with phenotype. We also identi-
ﬁed a missense mutation in an individual with AM, brain,
and hand anomalies. Furthermore, we found that BMP4
and HH signaling genes were expressed in a cospatial and
cotemporal fashion in the eye, brain, and hand of develop-
ing human embryos. We also identiﬁed four cases with
mutations in both BMP4 and SHH/PTCH1, suggesting the
two pathways may act synergistically in eye development
in humans.
Deletions in 14q22-q23 are known to be associated with
AM, brain, pituitary, and ear anomalies (structural defects
and hearing loss), hypothyroidism, poly/syndactyly, clin-
odactyly, high arched palate, cryptorchidism, and develop-
mental delay.4,37 Similarly, our deletion cases had bilateral
AM associated with hypothyroidism, cryptorchidism, par-
tial callosal agenesis, sensorineural deafness, developmen-
tal delay, and cerebellar and pituitary abnormalities. The
hypothyroidism and cryptorchidism may be related to hy-
pothalamic-pituitary anomalies. Three eye development
genes, SIX6 (MIM 606326),OTX2, and BMP4, reside within
the 14q22-q23 region; Six6, which is expressed in the pitu-
itary,41 could potentially explain the hypopituitarism in
a contiguous gene syndrome; however, it does not appear
to be important in human AM.42 Although OTX2 has
been identiﬁed as one causative gene for AM,3 loss ofrican Journal of Human Genetics 82, 304–319, February 2008 313
function ofOTX2 does not explain pituitary or digit anom-
alies.4,5 Bmp4 is important in eye and digit development in
vertebrates, and therefore human BMP4 is an excellent
candidate gene for ocular, pituitary, and digit anomalies.
We identiﬁed a BMP4 frameshift mutation (c.226del2,
p.S76fs104X), which would result in haploinsufﬁciency
of the BMP4 protein in a family (case 3) with AM, retinal
dystrophy, myopia, and poly/syndactyly (Figure 1). The af-
fected family members have variable eye phenotypes rang-
ing from high myopia in the mother, maternal aunt, and
grandmother to unilateral anophthalmia and contralateral
microanterior segment, iris and chorioretinal coloboma,
and retinal dystrophy in the proband. The presence of ret-
inal dystrophy is of great signiﬁcance for two main rea-
sons: First, it suggests a role for BMP4 in retinal develop-
ment and maintenance and second, that individuals
with BMP4mutations may suffer a later, chronic deteriora-
tion of vision, sometimes in their only seeing eye, necessi-
tating appropriate advice regarding, for instance, learn-
ing of Braille. Three other individuals (cases 6 [BMP4
(c.370þ28G/A)], 9 and 14 [BMP4 (c.1217þ88C/T)]) had
ERGs in the better eye consistent with a retinal dystrophy.
Case 6 had generalized retinal dysfunction affecting the
cones more than the rods. Case 9 had moderate-to-severe
generalized retinal dysfunction affecting rods and cones,
similar to case 3, and case 14 had evidence of mild gener-
alized rod- and cone-system dysfunction. Because the ﬁnd-Figure 4. Expression Studies of BMP4,
SHH, PTCH1, GLI1, and GLI3 in the
Developing Human Brain
Coronal sections through the diencephalon
of CS17 and 18 human embryos were ana-
lyzed by in situ hybridization for the ex-
pression of BMP4 (A, F, K, N, and Q), SHH
(B, G, L, O, and R), PTCH1 (C, H, M, P,
and S), GLI1 (D and I), and GLI3 (E and
J). The following abbreviations are used:
Rp, Rathke’s pouch; Ir, Infundibular recess;
Lt, lamina terminalis; Mge, medial gangli-
onic eminence; Df, diencephalic floor; Tv,
third ventricle; Fp, floor plate; Dh, devel-
oping hypothalamus; Pcp, prechordal
plate; Lv, lateral ventricle; and Bl, basal
lamina. The scale bar for (A)–(E) represents
1000 mm, for (K)–(M), 1000 mm, for
(F)–(J), 200 mm, for (N)–(P), 100 mm,
and for (Q)–(R), 50 mm. Arrows indicate
areas of strong expression.
ing of AM and retinal dystrophy is
not universal in our cohort of AM pa-
tients, it suggests a homogeneity of
eye phenotype and suggests that
these sequence variations in BMP4
may be signiﬁcant. The proband, his
maternal grandmother, and his
grandmother’s sister have poly/syn-314 The American Journal of Human Genetics 82, 304–319, Februarydactyly, and interestingly, three 14q22-q23 deletion cases
with AM also have hand and feet poly/syndactyly.4,5
Individuals with BMP4 mutations may have underlying
brain anomalies and developmental delay. Case 3 and his
grandmother (BMP4 c.226del2) had structural cerebral
anomalies including enlarged trigones, widened sulci,
and partial callosal agenesis on MR imaging, indicative of
a primary-brain developmental disorder. The grandmother
in addition showed marked diffuse brain atrophy, suggest-
ing a progression of the disorder with age. Case 4 with
a c.278A/G change showed mild reduction in white mat-
ter and delayed myelination. Furthermore, by using DT,
which shows brain connections,22 we demonstrate signif-
icant asymmetry in thalamo-occipital connectivity in
case 3 with diminished left thalamocortical visual path-
ways and reduced callosal connectivity, especially between
primary sensorimotor cortices (Figures 2G–2J).25 The
changes discovered were undetectable by conventional im-
aging, demonstrating the beneﬁts DT offers in the study of
complex brain disease. The cerebral ﬁndings point to
amore complex underlying pathology, not only disturbing
ocular development but also independently affecting brain
development.
Our in situ hybridization studies show BMP4 is expressed
in early developing human eye, brain, and digits, and its
expression pattern correlates well with the range of pheno-
types observed in individuals with BMP4mutations. In the2008
early human developing eye, we demonstrate expression
of BMP4, SHH, PTCH1, GLI1, and GLI3 in the optic vesicle,
optic cup, and retina. Bmp4 has been shown to be ex-
pressed in the optic vesicle and optic cup in a number of
Figure 5. Digit Formation in the Human Embryo at CS20 and 23
All sectionswere cut across the dorsal ventral axis with respect to the
hand plate. In situ analysis of mRNA expression for BMP4 (A, D, G, J,
M, and P), SHH (B, E, H, K, N, and Q), and PTCH1 (C, F, I, L, O, and R).
(A)–(I) show CS20 stages; (J)–(R) show CS23 stages. The following
abbreviations are used: Iz, interdigital zone; Di, digit; Te, tendon;
Ca, cartilage; Jc, joint capsule; and Per, pericardium; and Dct, dense
connective tissue. The scale bar for (A)–(C) and that for (J)–(L) rep-
resent 1000 mm, for (D)–(F) and (M)–(O), 500 mm, and for (G)–(I)
and (P)–(R), 50 mm. Arrows indicate areas of strong expression.The Amevertebrate species and is required to enable the optic
vesicle to induce the lens by regulating Msx2 (MIM
123101).9 In Bmp4 homozygous null mutant embryos,
lens induction is absent,9 and consistent with this, we
demonstrate that BMP4 is expressed during early lens in-
duction and later in the lens (Figure 3). Bmp4 and Shh
induce expression of a number of transcription factors
such as Tbx5 (MIM 601620), Pax2 (MIM 167409), and
Vax2 (MIM 604295) within the eye17 and are believed to
establish a dorsoventral gradient throughout the eye ﬁeld.43
We demonstrate that BMP4 is expressed dorsally in the optic
vesicle anddeveloping optic cup andventrally atCS20when
optic-ﬁssure closure has completed, indicative of a require-
ment for Bmp4 signaling after formation of the optic cup.
This is further supported by the observation of ocular colo-
boma in four cases (1, 3, 4, and 8)with deletionormutations
in BMP4. Interestingly, both a disruption of SHH and its an-
tagonist PTCH1 can also lead to a failure of optic ﬁssure clo-
sure and coloboma formation,44,45 suggesting that the deli-
cate balance between agonist and antagonist is important.
In brain, we demonstrate that BMP4 expression is re-
stricted to the diencephalic ﬂoor, and such a result would
be consistent with a role in pituitary development (Fig-
ure 4) and would explain pituitary anomalies observed in
14q22-q23 deletion cases. Strong expression of SHH is
seen in the ﬂoor plate and the MGE of the diencephalon,
and such a ﬁnding is consistent with its role in patterning
of the central nervous system and oligodendrogenesis
within theMGE.33 TheMGE, which gives rise to inhibitory
neurons, has been shown to be absent in Shh/ em-
bryos.43 Ptch1 has been shown to act as a sponge for Shh,
preventing it from reaching cells further away,46 and the
expression of PTCH1 in the neuroepithelium lateral to
the ﬂoor plate may therefore be limiting the expression
of SHH. GLI3, which is a Shh antagonist47 andmay directly
regulate Bmp4 expression,48 is expressed in the ventral di-
encephalon. Gli3 is required for the speciﬁcation of dorsal
cell types and for the suppression of ventral cell types in
the forebrain.49
Patterning of the limb is controlled by secreted signals
(Bmp4, Shh, growth factors, and Wnt7a [MIM 601570])
that coordinate growth and morphogenesis along the an-
teroposterior, proximodistal, and dorsoventral axes. Digit
number is related to the width of the limb bud, which in
turn depends on the length of the apical ectodermal
ridge,50 a specialized ectoderm that runs around the distal
tip of the limb bud. In animals, both Bmp4 and Shh are ex-
pressed in the posterior part of the apical ectodermal
ridge.51,52 Furthermore, both a reduction of Bmp4 expres-
sion in conditional knockouts or an altered Shh expression
have been shown to result in polydactyly.53,54 BMP4 is ex-
pressed in the interdigital mesenchyme and the joint pri-
mordium (Figure 5). At later stages of limb development,
mesoderm between the digits undergoes regression by ap-
optosis, which is controlled by Bmp4, and leads to freeing
of the digits.55,56 The expression of BMP4 in the interdigi-
tal mesenchyme of humans is therefore consistent withrican Journal of Human Genetics 82, 304–319, February 2008 315
a similar role. At CS23, when apoptosis in the interdigital
zones has already occurred and the ﬁngers are almost to-
tally separate, BMP4 expression is restricted to the joint
forming region (Figure 5). A decrease in Bmp4 levels leads
to a lack of apoptosis in the mesoderm between the ﬁngers
and will result in syndactyly of the digits.55 Interestingly,
we ﬁnd that four of our cases (3, 4, 8, and 12) with BMP4
mutations had poly/syndactyly or other hand anomalies.
From our human embryo data alone, it would be predicted
that BMP4/SHH/PTCH1 are major genes in eye, pituitary,
and hand development.
Non-Mendelian inheritance patterns and variable ex-
pressivity of AM and other ocular developmental disorders
suggest complex mechanisms are at play, including multi-
genic inheritance and/or interaction with environmental
factors. Case 3 (BMP4 c.226del2 mutation) is the only fam-
ily member who has an additional c.1-125G/A change in
the 50 UTR of SHH (predicted to affect an exonic splicing
enhancer)—a combination that may have contributed to
a more severe eye phenotype of AM and retinal dystrophy
compared with other familymembers who havemyopia5
polydactyly. Our ﬁnding of cotemporal and cospatial ex-
pression of BMP4 and SHH in early developing human
eye, including retina, supports this (Figure 3). Two of our
cases (8 and 9) had a sequence variation in BMP4with addi-
tional intronic orUTRchanges inhighly conserved residues
in SHH, and one (case 7) had an additional mutation in
PTCH1. The Hh signaling pathway is critical for speciﬁca-
tion of midline ventral structures, eyes, and digits.57–59 In
humans, SHH mutations cause holoprosencephaly (MIM
236100), cyclopia (MIM 236100), and colobomatous mi-
crophthalmia,44,60,61 andmutations in the SHH antagonist
receptor, PTCH1, can also cause colobomatous micro-
phthalmia as part of Gorlin syndrome (naevoid basal cell
carcinoma syndrome).45,62 Interestingly, Gorlin syndrome
is only rarely associated with eye defects, and when they
do occur, most appear to be mild, (e.g., isolated coloboma
or epiretinal membranes) with normal ERGs;45,63 our sub-
ject (case 7) had severe bilateral eye anomalies, suggesting
that the combination of a PTCH1 and BMP4 mutation
may predispose to or worsen an ocular phenotype inGorlin
syndrome. Synergism between Bmp4 and Hh pathways has
been observed in animal models whereby enhancement of
preaxial polydactyly with additional syndactyly is seen
when Bmp4þ/ mice are backcrossed to Gli3þ/ or Alx4þ/
(MIM 605420) mice.15 More recently, Morcillo and col-
leagues have demonstrated that optic ﬁssure closure in
themouse requires the sequential and independent activity
of Bmp7 and Shh.31 Our ﬁnding of two cases who have mu-
tations in BMP4 and SHH and who also have poly/syn-
dactyly is highly signiﬁcant and supports an interaction
between these two pathways in humans.
There are common features between our cases and indi-
viduals with Bardet Biedl syndrome (BBS [MIM 209900])
including rod-cone dystrophy, polydactyly, hypogonad-
ism, renal anomalies, reduced hearing, and developmental
delay.64 However, our cases do not exhibit obesity, and BBS316 The American Journal of Human Genetics 82, 304–319, Februaryis not associated with AM. Nevertheless, there are common
gene networks, e.g., the SHH signaling pathway, that could
explain overlapping phenotypes.65 A further example of
overlapping phenotypes and gene expression patterns is
seen with PITX2 (the gene for Reiger syndrome) (MIM
601542) and BMP4.66,67 Mutations in the PITX2 homeo-
box gene cause ocular (anterior segment), brain (pituitary),
and dental anomalies.68,69 These features are also observed
in some of our cases; for instance, case 9 (BMP4 c.1217þ
88C/T) had glaucoma, and Bmp4þ/ mice have anterior
segment abnormalities16 and cases 1, 2 (whole gene dele-
tions), and 3 (BMP4 c.226del2) had pituitary abnormalities.
Both BMP4 (Figure 4) and Pitx268 are expressed in Rathke’s
pouch, consistent with a role in pituitary development.
The combination of a BMP4 sequence variation and en-
vironmental factorsmayalso increase susceptibility toocular
malformation. Two cases (5 and6)whohave a c.370þ28G/
Amutationpredicted toaffect splicing inBMP4were exposed
topotential gestational insults (varicella exposure andmater-
nal carbamazepine intake). Although, both mutations oc-
curred in the noncoding region of BMP4, it is possible that
these changes could still be relevant.70 Interestingly, case 5
and 14 have additional loss of hearing, and it has recently
been reported that BMP4 heterozygous mice have structural
and functional deﬁcits in the inner ear71 and that hearing
anomalies are observed in individuals with a 14q22-q23
deletion.5,40 Case 6 has amore severe eye phenotype, retinal
dystrophy, developmental problems (motor and cognitive
delay), and a high arched palate, which is also interesting be-
cause Bmp4 is implicated in animal palate development72
andone 14q22-q23 deletion case had a high arched palate.38
Recent exciting work has suggested that Hsp90AA1 (MIM
140571)/Hsp90AB1 (MIM 140572), one of a class of chaper-
one proteins,may play a protective role during development
and oncogenesis and that its dysfunction may allow the
manifestation of otherwise safe and probably highly preva-
lent low-penetrant mutations.73 Thus, gestational insults
such as those described for cases 5 and 6 may be signiﬁcant.
Our study is the ﬁrst to combine the ex vivo exami-
nation of gene expression patterns with noninvasive
in vivo imaging of white-matter pathways in the human
brain, and most signiﬁcantly, we demonstrate that BMP4
is an important gene for ocular malformations associated
with poly/syndactyly, pituitary, and brain developmental
anomalies. The identiﬁcation of further low-penetrant
gene variations may provide insights into human develop-
mental eye disease and will be possible once large-scale
screening of genes can be undertaken.Acknowledgments
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